Ann Surg Treat Res.  2014 Dec;87(6):311-318. 10.4174/astr.2014.87.6.311.

Effect of triclosan-coated sutures on surgical site infection after gastric cancer surgery via midline laparotomy

• Jung KH
• Oh SJ
• Choi KK
• Kim SM
• Choi MG
• Lee JH
• Noh JH
• Sohn TS
• Bae JM
• Kim S

• KMID: 2167087
• DOI: http://doi.org/10.4174/astr.2014.87.6.311

Abstract

PURPOSE
Surgical site infection (SSI) after open abdominal surgery is still a frequently reported nosocomial infection. To reduce the incidence of SSI, triclosan-coated sutures with antiseptic activity (Vicryl Plus) were developed. The aim of this study was to analyze the effect of Vicryl Plus on SSI after gastric cancer surgery via midline laparotomy.
METHODS
A total of 916 patients who underwent gastric cancer surgery at Samsung Medical Center between December 2009 and September 2011 were prospectively collected. We examined the occurrence of SSI (primary endpoint), assessments of wound healing (secondary endpoint). They were evaluated postoperatively on days 3, 7, and 30.
RESULTS
Of the 916 patients, 122 were excluded postoperatively by screening (out of the study protocol, adverse events, etc.). The remaining 794 patients were enrolled and monitored postoperatively. The cumulative SSI incidence was 11 cases (1.39%; 95% confidence interval [CI], 0.77-2.50) on day 30. Seromas were most frequently detected in wound healing assessments, with a cumulative incidence of 147 cases (18.51%; 95% CI, 15.98-21.39) on day 30.
CONCLUSION
The use of triclosan-coated sutures (Vicryl Plus) for abdominal wall closure can reduce the number of SSIs in gastric cancer surgery.

Keyword

Sutures; Surgical wound infection; Laparotomy; Stomach neoplasms

MeSH Terms

Abdominal Wall
Cross Infection
Humans
Incidence
Laparotomy*
Mass Screening
Polyglactin 910
Prospective Studies
Seroma
Stomach Neoplasms*
Surgical Wound Infection
Sutures*
Wound Healing
Polyglactin 910

Figure

• 

  Fig. 1 Flow chart of patients through the study.

Reference

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993; 6:428–442.

2. Israelsson LA, Jonsson T, Knutsson A. Suture technique and wound healing in midline laparotomy incisions. Eur J Surg. 1996; 162:605–609.

3. Franchi M, Ghezzi F, Benedetti-Panici PL, Melpignano M, Fallo L, Tateo S, et al. A multicentre collaborative study on the use of cold scalpel and electrocautery for midline abdominal incision. Am J Surg. 2001; 181:128–132.

4. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003; 36:592–598.

5. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999; 27:97–132.

6. Nichols RL. Preventing surgical site infections. Clin Med Res. 2004; 2:115–118.

7. Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005; 140:174–182.

8. Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt). 2002; 3:Suppl 1. S79–S87.

9. Gomez-Alonso A, Garcia-Criado FJ, Parreno-Manchado FC, García-Sanchez JE, García-Sanchez E, Parreno-Manchado A, et al. Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. J Infect. 2007; 54:82–88.

10. Mingmalairak C, Ungbhakorn P, Paocharoen V. Efficacy of antimicrobial coating suture coated polyglactin 910 with tricosan (Vicryl plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thai. 2009; 92:770–775.

11. Justinger C, Schuld J, Sperling J, Kollmar O, Richter S, Schilling MK. Triclosan-coated sutures reduce wound infections after hepatobiliary surgery--a prospective non-randomized clinical pathway driven study. Langenbecks Arch Surg. 2011; 396:845–850.

12. Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK. Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery. 2009; 145:330–334.

13. National Health Insurance Corporation. Statistics on major surgical procedures in Korea, 2009 [Internet]. Seoul: National Health Insurance Corporation;c2011. cited 2010 Dec 24. Available from: http://www.nhic.or.kr.

14. Kim ES, Kim HB, Song KH, Kim YK, Kim HH, Jin HY, et al. Prospective nationwide surveillance of surgical site infections after gastric surgery and risk factor analysis in the Korean Nosocomial Infections Surveillance System (KONIS). Infect Control Hosp Epidemiol. 2012; 33:572–580.

15. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32:470–485.

16. Galal I, El-Hindawy K. Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg. 2011; 202:133–138.

17. Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg. 1981; 194:35–41.

18. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg. 2006; 203:481–489.

19. Uff CR, Scott AD, Pockley AG, Phillips RK. Influence of soluble suture factors on in vitro macrophage function. Biomaterials. 1995; 16:355–360.

20. Fiss EM, Rule KL, Vikesland PJ. Formation of chloroform and other chlorinated byproducts by chlorination of triclosancontaining antibacterial products. Environ Sci Technol. 2007; 41:2387–2394.

21. Rasic Z, Schwarz D, Adam VN, Sever M, Lojo N, Rasic D, et al. Efficacy of antimicrobial triclosan-coated polyglactin 910 (Vicryl* Plus) suture for closure of the abdominal wall after colorectal surgery. Coll Antropol. 2011; 35:439–443.

22. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003; 290:1868–1874.